Literature DB >> 15846082

An optimized conditional suicide switch using doxycycline-dependent expression of human tBid.

Anja Knott1, Lars Drueppel, Thomas Beyer, Kristin Garke, Christian Berens, Martin Herrmann, Wolfgang Hillen.   

Abstract

We have examined in a HeLa model system whether tight doxycycline-dependent expression of human tBid can be used as a fast and efficient suicide switch. A stably transfected cell line expressing human tBid in a strictly dox-dependent manner showed fast and efficient killing with up to 98 % specific cell death 24 h after induction. The survival rate was only 0.6 % after eleven days of dox treatment. Very low amounts of tBid were sufficient to induce apoptosis indicating that stringent control of the dox-dependent suicide gene is essential for cell survival in the absence of inducer. Using human tBid, an endogenous effector protein with low immunogenic potential, and doxycycline, an inducer with low cytotoxicity and a long record of safe use in humans, this conditional suicide switch provides a tool for various applications, e.g., adoptive immune transfer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15846082     DOI: 10.4161/cbt.4.5.1658

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  3 in total

1.  Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling.

Authors:  Christian Berens; Stephanie Bisle; Leonie Klingenbeck; Anja Lührmann
Journal:  J Vis Exp       Date:  2015-06-25       Impact factor: 1.355

2.  Repeated exposure of epithelial cells to apoptotic cells induces the specific selection of an adaptive phenotype: Implications for tumorigenesis.

Authors:  Lanfei Feng; Snezana Vujicic; Michael E Dietrich; Natalia Litbarg; Suman Setty; Angelika Antoni; Joyce Rauch; Jerrold S Levine
Journal:  J Biol Chem       Date:  2018-05-16       Impact factor: 5.157

3.  A suicide gene approach using the human pro-apoptotic protein tBid inhibits HIV-1 replication.

Authors:  Peter M Huelsmann; Andreas D Hofmann; Stefanie A Knoepfel; Jasmin Popp; Pia Rauch; Francesca Di Giallonardo; Christina Danke; Eva Gueckel; Axel Schambach; Horst Wolff; Karin J Metzner; Christian Berens
Journal:  BMC Biotechnol       Date:  2011-01-11       Impact factor: 2.563

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.